IL17A and Hepatic fibrosis: A traditional Chinese medicine component–disease–target–pathway network (435 nodes, 3021 edges) further emphasized the role of inflammatory (TNF, IL-17), metabolic (lipid metabolism), and oncogenic (cancer pathways, endocrine resistance) signaling pathways in mediating the pharmacological effects of BJXZ pills on liver fibrosis (Fig. 1F).